Fig. 1 · Structure
Documents & Downloads
Vutrisiran
siRNA Agent
Vutrisiran is an investigational small interfering ribonucleic acid (siRNA) agent targeting transthyretin (TTR). This liver-directed compound is designed to reduce the production of TTR, making it a valuable tool for research into TTR-mediated amyloidosis. Vutrisiran facilitates studies aimed at understanding the molecular mechanisms of amyloidogenesis and potential therapeutic strategies for related diseases.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1867157-35-4 |
| Applications | siRNA Agent |
| Molecular Weight | 16345.00 |
| Synonyms | ALN-TTRsc02 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.